​​AAC​R Science Series at the FDA

The
AACR Science Series at the FDA sessions began in July 2012. This series brings scientific leaders to the FDA campus to present cutting-edge advances in cancer biology to FDA scientific review staff and to foster the development of relationships between FDA reviewers and external scientific experts. Since January 2013, the AACR has been offering CME credits for these sessions.​